DeSci & Network States
Conference

Vincent Weisser is a dedicated advocate for decentralized science and AI, known for his work on projects like VitaDAO, which funds longevity research, and Molecule, a platform for scientific funding. He is passionate about democratizing access to cutting-edge technologies and scientific progress, aiming to create a future where advanced AI and biotechnology are accessible to all. Vincent's diverse interests and contributions span across AI, biotechnology, energy, and more, making him a key figure in the tech and science communities.

Kai Micah Mills is the CEO of Cryopets, a startup specializing in cryopreservation for pets, and a co-founder of CryoDAO, a decentralized organization funding cryonics research. With a background as a tech entrepreneur and Thiel Fellow, Kai is dedicated to advancing cryopreservation technologies and making significant contributions to the field of life extension.

Patri Friedman is a prominent libertarian and anarcho-capitalist, known for founding The Seasteading Institute, which explores the creation of sovereign ocean colonies. He is also the General Partner at Pronomos Capital, a venture capital firm focused on developing experimental cities in developing countries. Patri's innovative approaches to governance and urban development continue to inspire discussions on alternative political and social systems.

Mark Lutter is the Founder and Executive Chairman of the Charter Cities Institute, a nonprofit organization dedicated to building the ecosystem for charter cities. He is also the CEO of Braavos Cities, a charter city development company. With a PhD in economics from George Mason University, Mark's work focuses on innovative governance and economic development through the creation of new cities. His vision is to demonstrate better governance mechanisms and attract talent to these new urban centers.

Eli Mohamad is a serial entrepreneur and scientist, currently serving as an Entrepreneur in Residence at Narwhal Sciences, where he is incubating the Fraktus Protocol. He is a core team member of CryoDAO, focusing on advancing cryopreservation research, and has co-founded several organizations, including X-Therma and the Organ Preservation Alliance. Eli's work spans various cutting-edge fields, from tissue preservation to decentralized science, showcasing his commitment to innovation and scientific progress.

Hugo Bailly is the co-founder of Erectus DAO, a decentralized autonomous organization focused on advancing regenerative medicine and stem cell therapies. With a background in urology and extensive research experience, Hugo is dedicated to exploring innovative treatments for conditions such as erectile dysfunction and Peyronie's disease. His work aims to harness the potential of stem cells to improve patient outcomes and promote overall health.

Andrew Verbinnen is a co-founder of HairDAO, a decentralized science (DeSci) project aimed at tackling hair loss through innovative funding and research models. With a background in Government from Hamilton College and experience in private equity and cryptocurrency, Andrew transitioned to the DeSci space to address the misaligned incentives in pharmaceutical research. His work focuses on leveraging blockchain technology to democratize early-stage research and improve patient outcomes.

Mgoes is the co-founder of BiohackerDAO, a citizen science organization dedicated to data-driven self-optimization and radical human enhancement. He advocates for a minimalist, evidence-based approach to longevity, rigorously testing interventions and eliminating those that don't show clear, consistent improvements in his biomarkers. Mgoes focuses on actions that offer significant leverage, optimizing his daily routine for maximum impact. He is passionate about combining science and community collaboration to push the boundaries of human potential.

Ethan Perlstein is a visionary scientist-entrepreneur dedicated to eradicating rare diseases. As Founder/CEO of Perlara PBC, the first biotech public benefit corporation, Ethan has pioneered healthspan-extending therapeutics and cures for rare metabolic disorders. He also leads Maggie's Pearl LLC, advancing precision medicines for ultra-rare conditions, and recently launched Curetopia, a groundbreaking DAO aiming to transform rare disease treatment through decentralized collaboration. With a PhD from Harvard and impactful roles at Princeton and the Reeve Foundation, Ethan blends innovation and leadership to redefine biotech’s role in global health.

Erick Brimen is an entrepreneur and investor with extensive experience in finance and socioeconomic development. He is the founder and CEO of Próspera, a special economic zone in Honduras designed to foster economic growth and innovation. He served as CFO for Latin America at the Borealis Group, where he led the creation of multiple business units. As an entrepreneur, Erick founded ComparaMejor.com, a leading online insurance brokerage in Colombia, and NeWay Capital, focusing on alternative real estate strategies that drive socioeconomic development.

Dr. Tomer Landsberger is an entrepreneur and scientist with extensive experience in immunology and systems biology. He is the co-founder of Sciborg DAO, an organization dedicated to prolonging and enhancing human existence through the development of synthetic replacements, aiming to conquer death and enable long-term preservation of consciousness. Dr. Landsberger's scientific background includes significant contributions to the understanding of immune surveillance and senescence. Through his leadership at Sciborg DAO, Dr. Landsberger aims to integrate cutting-edge scientific research with collaborative, decentralized approaches to address the fundamental challenges of aging and mortality.

Jasmine Smith is an entrepreneur and health information specialist with a diverse background in health data management and community engagement. She is the Chief Executive Officer of Rejuve.AI, a decentralized AI-driven longevity research network committed to making healthspan extension solutions accessible and affordable to all. Under her leadership, Rejuve.AI leverages artificial intelligence and blockchain to unite individuals, clinics, researchers, and health supply vendors, fostering collaborative efforts to discover and develop interventions that promote healthy longevity. Through her work at Rejuve.AI, Ms. Smith aims to democratize access to longevity solutions, ensuring that advancements in healthspan extension benefit people worldwide.

Erik Van Winkle is an entrepreneur and operations strategist with extensive experience in decentralized science and blockchain technology. He is the Head of Operations at DeSci Labs, an organization focused on leveraging decentralized technologies to advance scientific research and innovation. Erik’s work centers on building infrastructure for open collaboration, improving research accessibility, and integrating Web3 principles into the scientific ecosystem. Through his leadership, he aims to drive the transformation of scientific funding, publishing, and data-sharing to accelerate breakthroughs in biotechnology and beyond.

Hannah Janjua is an entrepreneur and biomedical scientist focused on accelerating biotechnology through innovative decentralized platforms. She is the Co-Founder and Head of Ecosystem Development at PeptideDAO, a pioneering venture accelerating peptide research to transform health ecosystems. Hannah's scientific background includes a BSc in Biomedical Sciences from King's College London, where she showcased entrepreneurial leadership by securing a silver medal for an Alzheimer's treatment project at the prestigious iGEM competition. Her expertise bridges biomedicine, strategic partnership development, and practical innovation, aiming to unlock impactful solutions for real-world health applications.

Tim Maupin is a New York City-based director, visual effects artist, and Emmy Award-winning cinematographer with over a decade of experience in the film industry. Demonstrating a profound interest in the longevity movement, Tim directed "The Last Generation to Die," a short film set in a future where science begins to halt aging, which is currently in development as a full feature film. Furthering his dedication to the field, Tim produced the "Lifespan Docs" series for Lifespan.io, featuring short documentaries that delve into personal stories related to life extension and aging. This series aims to humanize the scientific discourse on longevity by presenting diverse perspectives. Tim is a core member and co-creator of JellyfishDAO, which seeks to fund and promote longevity-focused films, series, and media to reshape public perceptions, inspire audiences, and accelerate societal acceptance of healthy longevity through the power of storytelling. Through his multifaceted projects, Tim Maupin continues to bridge the gap between art and science, utilizing his cinematic expertise to explore and promote the possibilities of human longevity.

​Daniel Sollinger is a veteran filmmaker with a career spanning over four decades, during which he has produced an extensive portfolio of feature films, commercials, and music videos. In recent years, Daniel has channeled his storytelling expertise into the longevity movement. He co-founded JellyfishDAO, a decentralized autonomous organization uniting filmmakers, life extension experts, and blockchain innovators to create media that positively portrays life extension and healthspan technologies. His commitment to the cause is further exemplified by his role in organizing Bloom City, a pop-up village in Los Angeles set for July-August 2025. This initiative brings together longevity thought leaders, innovators, scientists, and entertainment creators to catalyze a cultural revolution prioritizing extended and enhanced human life. Daniel's dedication to merging storytelling with scientific advancement underscores his belief in the power of media to evoke emotions and inspire change within the longevity movement.

‍

Zoltan Istvan is a futurist, entrepreneur, and leading figure in the transhumanist movement, dedicated to exploring the fusion of technology and human biology to overcome natural limitations. He is the founder of the Transhumanist Party and author of "The Transhumanist Wager," a philosophical science fiction novel that has sparked extensive dialogue among futurists. Istvan's diverse career includes experience as a journalist for the National Geographic Channel, where he covered stories worldwide. His work often focuses on futurist and transhumanist themes, aiming to bring attention to the possibilities of enhancing human capabilities through technology.​ In the political arena, Istvan has been an advocate for science and technology's role in society. His diverse background and commitment to exploring the intersection of technology and human potential continue to influence discussions on the future of human enhancement and longevity.

Freya Chen is the Managing Partner at BGA (Blockchain for Good Alliance), where she leads core strategy, incubation efforts, and strategic partnerships. Passionate about leveraging blockchain to address real-world challenges, Freya actively identifies and supports high-impact projects by connecting them with the right resources and collaborators. In 2024 alone, Freya engaged with over 300 projects, organized large-scale events, built a strong network of 10+ Advisors, and successfully helped key projects secure $1 million in liquidity funding from Bybit. Her work reflects a deep commitment to empowering builders and advancing blockchain’s role in sustainable development.

Ethan Berg is an entrepreneur and investor with a background in management consulting and private equity. He is the founder of the Winthrop Estate in Lenox, Massachusetts, a meticulously restored Gilded Age mansion that serves as both a private residence and a cultural venue. Under his stewardship, the estate has hosted events such as TEDx Berkshires, chamber music concerts, and literary readings, fostering a space for intellectual and artistic engagement. Prior to acquiring the Winthrop Estate in 2003, Ethan held a position at the Monitor Group, a management consulting firm, and managed a private investment partnership.